Investment
Features
FeesSafety
Academy
More
Pluang+

Software and IT services undervalued vs 11-year averages; broad tech ETF TTEQ has limits

Market News
18 Sep 2026
Seeking Alpha
View Source
Neutral
Software and IT services undervalued vs 11-year averages; broad tech ETF TTEQ has limits

Software and IT services stocks appear undervalued compared to their 11-year historical averages, while other tech subsectors remain overvalued. The T Rowe Price Technology ETF (TTEQ) offers broad exposure to the tech sector globally but has a short track record, relatively high fees, and average performance, which may limit investor confidence. The article highlights eight tech stocks that were cheaper than their peers in September, providing potential opportunities for value-focused investors. This analysis is part of a monthly series that uses value, quality, and momentum metrics to assess the technology sector and related ETFs.

The T Rowe Price Technology ETF (TTEQ) and its sector context are shown here with recent market data. For readers following technology stocks, of 150 priced US tech stocks tradable on Pluang, 71 rose and 71 fell today. Notable movers include NOK at USD 10.78 with a 1-day change of +1.60%, ACN at USD 187.35 down -1.55%, and AXTI at USD 68.78 up +1.52%. This data is as of Sep 18, 2026 18:51 WIB.

More News

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
1 hour ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
1 hour ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
2 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim raises price target for Restaurant Brands International to $86 amid growth and share buybacks

Guggenheim has raised its price target for Restaurant Brands International (QSR) to $86 from $85 and reiterated a Buy rating, reflecting confidence in the company's strategic growth. Restaurant Brands International is enhancing shareholder value thro...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App